Immunic AG | WebDisclosure

PRESS RELEASE

published on 09/04/2024 at 12:30, 1 year 9 months ago

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome
Immunic announces enrollment of the first patient in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium for Post COVID Syndrome. Study aims to suppress EBV reactivation and fatigue symptoms

Clinical Trial Immunic Vidofludimus Calcium Phase 2 Post COVID Syndrome
BRIEF

published on 08/28/2024 at 12:35, 1 year 10 months ago

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September

Multiple Sclerosis Immunic Vidofludimus Calcium R&D Day Scientific Conferences
BRIEF

published on 08/28/2024 at 12:35, 1 year 10 months ago

Immunic organise une journée de recherche et développement sur la sclérose en plaques et participe à des conférences scientifiques et d'investisseurs en septembre

Sclérose En Plaques Conférences Scientifiques Journée R&D Immunique Vidofludimus Calcique
PRESS RELEASE

published on 08/28/2024 at 12:30, 1 year 10 months ago

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
Immunic to host Multiple Sclerosis R&D Day & participate in conferences. Immunic, Inc. develops oral therapies for autoimmune diseases

Investor Conferences Multiple Sclerosis Immunic R&D Day Scientific Conferences
BRIEF

published on 08/08/2024 at 12:35, 1 year 10 months ago

Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Financial Results Biotechnology Clinical Trials Multiple Sclerosis Immunic
BRIEF

published on 08/08/2024 at 12:35, 1 year 10 months ago

Immunic, Inc. publie ses résultats financiers du deuxième trimestre 2024 et fait le point sur son entreprise

Résultats Financiers Biotechnologie Essais Cliniques Sclérose En Plaques Immunitaire
PRESS RELEASE

published on 08/08/2024 at 12:30, 1 year 10 months ago

Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q2 2024 financial results and corporate update, appoints new COO & strengthens BOD. Webcast on August 8. Ongoing trials remain on track

Financial Results Clinical Trials Corporate Update Immunic Inc. COO Appointment
BRIEF

published on 08/01/2024 at 12:35, 1 year 10 months ago

Immunic, Inc. to Announce Financial Results for Q2 2024 and Provide Corporate Update

Biotechnology Clinical Trials Webcast Immunic, Inc. Q2 Financial Results
BRIEF

published on 08/01/2024 at 12:35, 1 year 10 months ago

Immunic, Inc. annoncera ses résultats financiers pour le deuxième trimestre 2024 et fournira une mise à jour de l'entreprise

Biotechnologie Immunic, Inc. Webdiffusion Essais Cliniques Résultats Financiers Du Deuxième Trimestre
PRESS RELEASE

published on 08/01/2024 at 12:30, 1 year 10 months ago

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Immunic, Inc. to announce Q2 2024 financial results and corporate update on August 8, 2024, including webcast participation details. Company developing therapies for inflammatory diseases

Financial Results Webcast Immunic Inc. Q2 2024 Inflammatory Diseases

Published on 06/29/2026 at 09:01, 1 hour 5 minutes ago

HM Exploration Discovers New Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 06/27/2026 at 16:50, 1 day 17 hours ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 8 hours ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 days 10 hours ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 2 days 11 hours ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting

View all ACCESSWIRE

Published on 06/29/2026 at 09:56, 10 minutes ago

EQS-Adhoc: Management Board of FamiCord AG resolves on intended transfer of stock exchange listing from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/29/2026 at 09:50, 16 minutes ago

Buyglobal Launches Summer Sale 2026 to Make Quality Living More Accessible
Published on 06/29/2026 at 09:50, 16 minutes ago

Digital Intelligence Powering Energy Storage, Driving a Greener Future: Sermatec Showcases Full-Scenario Energy Storage Solutions at Intersolar Europe 2026
Published on 06/29/2026 at 09:25, 41 minutes ago

EQS-Adhoc: Gerresheimer AG: Publication of the 2025 financial statements on June 29, 2026 / Annual General Meeting on September 1, 2026 / Adjustment of the 2026 guidance
Published on 06/29/2026 at 09:00, 1 hour 6 minutes ago

Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY

View all EQS

Published on 06/26/2026 at 17:45, 2 days 16 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 2 days 16 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 2 days 16 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 2 days 19 hours ago

Safran information
Published on 06/26/2026 at 14:44, 2 days 19 hours ago

Information Safran

View all LES ECHOS COMFI WIRE

News